These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 4226739)
1. Some 6-substituted nicotinamides: synthesis and antineoplastic activities. Ross WC Biochem Pharmacol; 1967 Apr; 16(4):675-80. PubMed ID: 4226739 [No Abstract] [Full Text] [Related]
2. Some alkylating derivatives of nicotinic acid. Synthesis and antineoplastic activities. Ross WC J Med Chem; 1967 Mar; 10(2):257-9. PubMed ID: 6034072 [No Abstract] [Full Text] [Related]
3. Synthesis of potential antineoplastic agents. XIV. Some 2-substituted 2,3-dihydro-1h-perimidines. Wasulko W; Noble AC; Popp FD J Med Chem; 1966 Jul; 9(4):599-601. PubMed ID: 4165378 [No Abstract] [Full Text] [Related]
4. Synthesis of potential antineoplastic agents. 35. Phosphorus-containing structural analogs of myleran. Struck RF J Med Chem; 1966 Mar; 9(2):231-4. PubMed ID: 5911803 [No Abstract] [Full Text] [Related]
5. Carcinostatic sulfonic acid esters of butyne- and butane-1,4-diols. Earl RA; Harmon RE J Med Chem; 1966 Sep; 9(5):776-8. PubMed ID: 5969056 [No Abstract] [Full Text] [Related]
6. Imidazoles. II. 5(or 4)-(Monosubstituted triazeno)imidazole-4(or 5)-carboxamides. Shealy YF; Krauth CA J Med Chem; 1966 Jan; 9(1):35-8. PubMed ID: 5958957 [No Abstract] [Full Text] [Related]
7. Potential carcinolytic agents. V. Enamine mustards. Papanastassiou ZB; Bruni RJ; White E J Med Chem; 1967 Jul; 10(4):701-6. PubMed ID: 6037064 [No Abstract] [Full Text] [Related]
8. Aryl-2-halogenoalkylamines. XXII. Derivatives of phenoxyacetic acid: synthesis and antineoplastic activities. Artico M; Ross WC Biochem Pharmacol; 1968 Jun; 17(6):873-82. PubMed ID: 5661350 [No Abstract] [Full Text] [Related]
9. Synthesis of potential antineoplastic agents. XV. Some l,4-bisamides of 1,2,3,4-tetrahydroquinoxaline. Schuyler P; Popp FD; Noble AC; Alwani DW; Masters BR J Med Chem; 1966 Sep; 9(5):704-7. PubMed ID: 6007964 [No Abstract] [Full Text] [Related]
10. Aryl-2-halogenoalkylamines. 23. Derivatives of oxanilic acid and salicylic acid: synthesis and antineoplastic activities. Artico M; Ross WC Biochem Pharmacol; 1968 Jun; 17(6):883-91. PubMed ID: 5661351 [No Abstract] [Full Text] [Related]
11. Aryl-2-halogenoalkylamines. XXIV. Derivatives of o-, m- and p-aminophenol: synthesis and antineoplastic activities. Artico M; Ross WC Biochem Pharmacol; 1968 Jun; 17(6):893-8. PubMed ID: 5661352 [No Abstract] [Full Text] [Related]
12. Some antitumor agents derived from benzaldehyde nitrogen mustards. Florvall L Acta Pharm Suec; 1970 Apr; 7(2):87-104. PubMed ID: 5421623 [No Abstract] [Full Text] [Related]
13. The basis for the disparate sensitivity of L1210 leukemia and Walker 256 carcinoma to a new triazine folate antagonist. Skeel RT; Sawicki WL; Cashmore AR; Bertino JR Cancer Res; 1973 Nov; 33(11):2972-6. PubMed ID: 4748449 [No Abstract] [Full Text] [Related]
14. Irreversible enzyme inhibitors. 173. Cure of Walker 256 ascites by reversible and irreversible inhibitors of dihydrofolic reductase derived from 1-(substituted-phenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine. Baker BR; Vermeulen NM; Ashton WT; Ryan AJ J Med Chem; 1970 Nov; 13(6):1130-40. PubMed ID: 5479852 [No Abstract] [Full Text] [Related]
18. Evaluation of the antitumor activity of rifamycin SV. Adamson RH Arch Int Pharmacodyn Ther; 1971 Jul; 192(1):61-5. PubMed ID: 5093193 [No Abstract] [Full Text] [Related]
19. Some organoboron compounds containing a bis(2-chloroethyl)amino group joined to boron. Shealy YF; Struck RF J Med Chem; 1969 Sep; 12(5):907-11. PubMed ID: 5812211 [No Abstract] [Full Text] [Related]
20. 1,3,2-dioxaphosphorinane 2-oxides. IV. Preparation of some 2-substituted-5-carbomethoxy-5-methyl-1,3,2-dioxaphosphorinane 2-oxides as potential antitumor agents. Billman JH; Roehrig GR J Pharm Sci; 1970 Jun; 59(6):861-3. PubMed ID: 5423097 [No Abstract] [Full Text] [Related] [Next] [New Search]